Nature Review: AI Drug Discovery Lacks Clinical Impact

A review in Nature Reviews Drug Discovery shared by Eric Topol highlights that despite a decade of progress, AI in drug discovery has shown limited clinical impact due to a lack of clinical data in model development, emphasizing a needed shift towards improving clinical decision-making.

2026-08-08 ~ 2026-08-09 · 2 related posts

• Nature Review: AI in drug discovery shows limited clinical impact, calls for focus on decision-making — Sufficient_Okra_2919 · 2026-08-08
• Nature Reviews Critiques AI in Drug Discovery: Absence of Clinical Evidence — EricTopol · 2026-08-09